Increased tumorigenicity of rat colon carcinoma cells after α1,2- fucosyltransferase FTA anti-sense cDNA transfection

International Journal of Cancer

Volumn 80, Issue 4, 1999, Pages 606-611

  Hallouin, Florence ^a   Goupille, Caroline ^a   Bureau, Valérie ^a   Meflah, Khaled ^a   Le Pendu, Jacques ^a  

^a INSTITUT DE BIOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; FUCOSYLTRANSFERASE;

ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTIGENICITY; ARTICLE; CARCINOGENICITY; CARCINOMA CELL; CELL MOTILITY; COLON CARCINOMA; DNA TRANSFECTION; ENZYME ACTIVITY; FUCOSYLATION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RAT; RNA SYNTHESIS;

ANIMALS; COLONIC NEOPLASMS; DNA, ANTISENSE; DNA, COMPLEMENTARY; FUCOSYLTRANSFERASES; MICE; MICE, SCID; NEOPLASM PROTEINS; RATS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033521880     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990209)80:4<606::AID-IJC20>3.0.CO;2-M     Document Type: Article

References (21)

1. GARRIGUES, J., ANDERSON, J., HELLSTRÖM, K.E. and HELLSTRÖM, I., Anti-tumor antibody BR96 blocks cell migration and binds to a lysosomal membrane glycoprotein on cell surface microspikes and ruffled membranes. J. Cell Biol., 125, 129-142 (1994).
2. GORELIK, E., XU, F., HENION, T., ANARAKI, F. and GALILI, U., Reduction of metastatic properties of BL6 melanoma cells expressing terminal fucoseα1-2-galactose after α12-fucosyltransferase cDNA transfection. Cancer Res., 57, 332-336 (1997).
3. GOUPILLE, C., HALLOUIN, F., MEFLAH, K. and LE PENDU, J., Increase of rat colon carcinoma cell tumorigenicity by α(1-2)fucosyltransferase gene transfection. Glycobiology, 7, 221-229 (1997).
4. HAKOMORI, S.L. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res., 56, 5309-5318 (1996).
5. HALLOUIN, F., GOUPILLE, C., LE CABELLEC, M., BARA, J. and LE PENDU, J., Expression of A and H blood-group and of CD44 antigens during chemical rat colonic carcinogenesis. Glycoconj. J., 14, 801-808 (1997).
6. HELLSTRÖM, K.E. and HELLSTRÖM, I., Immunologic enhancement of tumor growth. In: I. Green, S. Cohen and R.T. McCluskey (eds.), Mechanisms of tumor immunity, pp. 147-174. J. Wiley and Sons, Chichester (1977).
7. ITZKOWITZ, S., Carbohydrates changes in colon carcinoma. Acta pathol. microbiol. immunol. Scand. (Suppl. 27), 100, 173-180 (1992).
8. LABARRIÈRE, N., PIAU, J.P., OTRY, C., DENIS, M., LUSTENBERGER, P., MEFLAH, K. and LE PENDU, J., H blood group antigen carried by CD44V modulates tumorigenicity of rat colon carcinoma cells. Cancer Res., 54, 6275-6281 (1994).
9. MASUTANI, H. and KIMURA, H., Purification and characterization of secretory-type GDP-L-fucose: β-D-galactoside 2-α-L-fucosyltransferase from human gastric mucosa. J. Biochem., 118, 541-545 (1995).
10. MÉNORET, A., OTRY, C., LABARRIÈRE, N., BREIMER, M.E., PILLER, F., MEFLAH, K. and LE PENDU, J., The expression of carbohydrate blood group antigens correlates with heat resistance. J. Cell Sci., 108, 1691-1701 (1995).
11. MIYAKE, M. and HAKOMORI, S.I., A specific cell surface glycoconjugate controlling cell motility: evidence by functional monoclonal antibodies that inhibit cell motility and tumor cell metastasis. Biochemistry, 30, 3328-3334 (1991).
12. NAITOH, H., NAKAJIMA, T., NAGAMACHI, Y. and YAZAWA, S., A clinicopathological evaluation of anti-fucosylated antigens antibody (YB-2) in colorectal carcinoma. Glycosylation Dis., 1, 31-36 (1994).
13. NISHIHARA, S., KUDO, T., IKEHARA, Y. and NARIMATSU, H., Molecular mechanisms of Lewis B and Lewis Y antigen expression in human colon cancer. Glycoconj. J., 14 (Suppl. 1), S80 (1997).
14. b blood group antigens in human colon by α-2-L-fucosylation. Gut, 32, 287-293 (1991).
15. PATRY, Y. DOUILLARD, J.Y., MEFLAH, K. and LE PENDU, J., Immunization against a rat colon carcinoma by sodium butyrate-treated cells but not by interleukin-2 secreting cells. Gastroenterology, 109, 1555-1565 (1995).
16. PIAU, J.P., LABARRRIÈRE, N., DABOUIS, G. and DENIS, M.G., Evidence for two distinct α(1-2)fucosyltransferases differentially expressed throughout the rat colon. Biochem. J., 300, 623-626 (1994).
17. PREHN, R.T., Stimulatory effects of immune reactions upon the growth of untransplanted tumors. Cancer Res., 54, 908-914 (1994).
18. RAJAN, V.P., LARSEN, R.D., AJMERA, S., ERNST, L.K. and LOWE, J.B., A cloned human DNA restriction fragment determines expression of a GDP-L-fucose: β-D-galactoside 2-α-L-fucosyltransferase in transfected cells. Evidence for isolation and transferor the human H blood group locus. J. biol. Chem., 264, 11158-11167 (1989).
19. ROUQUIER, S., LOWE, J., KELLY, R.J. FERTITTA, A.L., LENNON, G.G. and GIORGI, D., Molecular cloning of a human genomic region containing the H blood group α(1,2)fucosyltransferase gene and two H locus-related DNA restriction fragments. Isolation of a candidate for the human Secretor blood group locus. J. biol. Chem., 270, 4632-4639 (1995).
20. SUN, J., THURIN, J., COOPER, H.S., WANG, P., MACKIEWICZ, M., STEPLEWSKI, Z. and BLASZCZYK-THURIN, M., Elevated expression of H type GDP-L-fucose: β-D-galactoside 2-α-L-fucosyltransferase is associated with human colon adenocarcinoma progression. Proc. nat. Acad. Sci. (Wash.). 92, 5724-5728 (1995).
21. YAZAWA, S., NAKAMURA, J., ASAO, T., NAGAMACHI, Y. SAGI, M., MATTA, K.L., TACHIKAWA, T. and AKAMATSU, M., M. Aberrant α1-2fucosyltransferases found in human colorectal carcinoma involved in the accumulation of Leb and Y antigens in colorectal tumors. Jpn. J. Cancer Res., 84, 989-995 (1993).